Home › Funds › 1607 Capital Partners, LLC › BME
1607 Capital Partners, LLC position in BME
BLACKROCK HEALTH SCIENCES TR COM · Financials
1607 Capital Partners, LLC reported holding 163,553 shares of BME (BLACKROCK HEALTH SCIENCES TR COM) in its Q2 2026 13F filing — a position valued at US$7.0M, representing 0.61% of its reported portfolio and ranking #42 among its reported holdings. 1607 Capital Partners, LLC has disclosed BME holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How 1607 Capital Partners, LLC's BME position evolved
1607 Capital Partners, LLC first disclosed a stake in BME in Q3 2023 at 88,092 shares (US$3.4M). The position peaked in Q3 2024 at 265,314 shares, worth US$11.1M. Across 12 filings, 1607 Capital Partners, LLC increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 163,553 shares valued at US$7.0M — a reduction of -69,707 shares quarter over quarter.. Notable position changes include a 95% increase in Q4 2023 (shares rose 2% over the following quarter), a 84% increase in Q2 2024 (shares rose 3% over the following quarter), a 50% increase in Q4 2025 (shares fell 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 88.09K | $3.45M | New |
| Q4 2023 | 171.74K | $6.95M | Add |
| Q1 2024 | 123.48K | $5.12M | Reduce |
| Q2 2024 | 227.79K | $9.31M | Add |
| Q3 2024 | 265.31K | $11.12M | Add |
| Q4 2024 | 176.01K | $6.68M | Reduce |
| Q1 2025 | 141.11K | $5.45M | Reduce |
| Q2 2025 | 153.50K | $5.60M | Add |
| Q3 2025 | 153.30K | $5.71M | Hold |
| Q4 2025 | 229.26K | $9.43M | Add |
| Q1 2026 | 233.26K | $8.98M | Add |
| Q2 2026 | 163.55K | $7.02M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BME and 13F data
BME (BLACKROCK HEALTH SCIENCES TR COM) is a Financials company. 23 other funds we track also report a position in BME — the largest reported positions include Nova R Wealth, Inc. (US$6.1M), Cypress Capital Management LLC (WY) (US$2.3M), Alessandra Capital Management, LLC (US$897K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BME
- Nova R Wealth, Inc. 140.94K sh · $6.05M · Q2 2026
- Cypress Capital Management LLC (WY) 53.31K sh · $2.29M · Q2 2026
- Alessandra Capital Management, LLC 20.32K sh · $896.50K · Q3 2026
More on 1607 Capital Partners, LLC
FAQ
How long has 1607 Capital Partners, LLC held BME?
1607 Capital Partners, LLC has disclosed BME holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is 1607 Capital Partners, LLC's current position in BME?
As of Q2 2026, 1607 Capital Partners, LLC holds 163.55K shares of BME (BLACKROCK HEALTH SCIENCES TR COM), valued at $7.02M, representing 0.61% of its reported portfolio and ranking #42.
Has 1607 Capital Partners, LLC been buying or selling BME?
In the latest 13F filing (Q2 2026), 1607 Capital Partners, LLC reduced its position in BME. The position peaked in Q3 2024 at 265.31K shares.
Which other funds hold BME?
Other major institutional holders of BME include Nova R Wealth, Inc., Cypress Capital Management LLC (WY), Alessandra Capital Management, LLC, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.